Stavudine and liver function

NEW YORK, August 2 (Praxis Press) At least 40 cases of hepatic steatosis and lactic acidosis have been reported in HIV-infected patients taking zidovudine and didanosine, but this syndrome has only rarely been reported in patients taking stavudine. Miller and colleagues reported four cases of hepatic steatosis, lactic acidosis, and myopathy in HIV-infected patients taking stavudine as part of a multidrug antiretroviral regimen. All patients had marked lactic acidosis, elevated levels of alanine

August 3, 2000

NEW YORK, August 2 (Praxis Press) At least 40 cases of hepatic steatosis and lactic acidosis have been reported in HIV-infected patients taking zidovudine and didanosine, but this syndrome has only rarely been reported in patients taking stavudine. Miller and colleagues reported four cases of hepatic steatosis, lactic acidosis, and myopathy in HIV-infected patients taking stavudine as part of a multidrug antiretroviral regimen. All patients had marked lactic acidosis, elevated levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), and evidence of fatty liver infiltration on CT scans. Other findings included elevated muscle enzymes, evidence of pancreatitis, biopsy-proven hepatic steatosis, and histologic features suggesting mitochondrial myopathy of muscle. Physicians should routinely monitor ALT and AST levels in patients taking stavudine to detect hepatic steatosis in its early stages.

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Streakers, Poopers, and Performers: The Wilder Side of Wildlife Cameras
AAAS